Replies to post #6418 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Catty, Zoom info updated (March 1,2017) Dr Snabes profile to Clinical Development and GPRD. They do global trials/studies for phases 1-4.

Dr Snabes

Now consider:

-Three New patent applications (This will maximize patent protection)
-Libigel trademark expiring (Without Ani submitting a replacement name)
-Anonymous discussion on Cafe Pharma about pipeline introductions and large Metabolics expansions on the horizon.(Note: no way to validate these claims yet)
- The new adminstration's FDA is expected to streamline the process to make drugs like Libigel available to the public.

I think it is just a matter of time for the Libigel story to be fully acknowledged and by 2019 Ani pharmaceuticals is bought out. (Humira Biosimilars start rolling out in late 2018)

JMHO.